Celnovte has a market-leading portfolio of Immunohistochemistry and in-situ hybridization. Celnovte is leading in its innovation of fully automated instrumentation, such as IHC stainers, H&E stainer, special stainer, cytopathology instrumentation and digital slide scanner and etc. Since their launch in 2018, Celnovte have successfully installed over 600 units of fully automated IHC stainers globally.
https://www.celnovte.com/